Please login to the form below

Not currently logged in
Email:
Password:

parenteral nutrition

This page shows the latest parenteral nutrition news and features for those working in and with pharma, biotech and healthcare.

Swift US approval for Baxter’s nutritional supplement

Swift US approval for Baxter’s nutritional supplement

There are a total of 242 products listed in the FDA' drug shortage list, 16 of which are for parenteral nutrition. “ ... FDA. “ Today's approval of Clinolipid will help in the effort to resolve this shortage so that patients have access to these

Latest news

  • Takeda’s Revestive becomes first approved drug in Europe for short bowel syndrome Takeda’s Revestive becomes first approved drug in Europe for short bowel syndrome

    Patients on parenteral nutrition also often experience a poor quality of life with difficulty sleeping, frequent urination and loss of independence, said Takeda. “ ... Overall, treatment with Revestive resulted in a 4.4 litre perweek reduction in

  • Building sustainable relationships Building sustainable relationships

    Examples include engaging with influential oncologists to improve supportive care, such as enteral and parenteral nutrition and working with stroke neurologists to improve long-term stroke care where their focus is

  • Full of promise

    Moreover, results showed a significant reduction in the use of opioid analgesics and parenteral nutrition.

  • Baiyunshan and Baxter finalise parenteral nutrition jv

    Parenteral nutrition products are administered intravenously to provide life-sustaining support for patients who cannot achieve adequate nutrition through other means. ... The new jv will manufacture and sell current Baiyunshan parenteral nutrition

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics